Skip to main content

Vida Ventures Advisors, LLC

SEC CIK
0001831423
Latest filing
Nov 3, 2025

Holdings in Q4 2021

Holdings as of Dec 31, 2021, filed Feb 10, 2022. Long positions only; changes compare share counts with Q3 2021.

Institution overview
Positions
8
0 vs. Q3 2021
Portfolio value
$267.3M
−$81.8M (−23.4%) vs. Q3 2021
Filed
Feb 10, 2022
SEC
Holdings of Vida Ventures Advisors, LLC in Q4 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
PRAXPraxis Precision Medicines, Inc.COM2,939,329$57.9M21.7%00.0%UnchangedHistory
KNTEKinnate Biopharma Inc.COM2,747,433$48.7M18.2%00.0%UnchangedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS3,931,818$44.3M16.6%00.0%UnchangedHistory
KRONKronos Bio, Inc.COM2,765,314$37.6M14.1%00.0%UnchangedHistory
DYNDyne Therapeutics, Inc.COM2,960,046$35.2M13.2%00.0%UnchangedHistory
ALLOAllogene Therapeutics, Inc.COM1,798,163$26.8M10.0%00.0%UnchangedHistory
LIANYLianBioSPONSORED ADS2,282,084$14.1M5.3%+2,282,084NewHistory
QTTBQ32 Bio Inc.COM770,845$2.81M1.0%00.0%UnchangedHistory

Sold out since Q3 2021 (1)

Positions held at the end of Q3 2021 that are gone from this filing.

Positions of Vida Ventures Advisors, LLC sold out since Q3 2021
SecurityClassShares in Q3 2021Value in Q3 2021% of portfolio in Q3 2021History
OYSTOyster Point Pharma, Inc.COM640,070$7.58M2.2%History